HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-interleukin 6 receptor antibody tocilizumab was not satisfactory for acute attack of Behçet's uveitis in three consecutive patients.

AuthorsChan Zhao, Jinjing Liu, Hang Song, Jing Shi, Meifen Zhang, Wenjie Zheng
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) Vol. 40 Issue 8 Pg. 1600 (09 2022) ISSN: 0392-856X [Print] Italy
PMID35699064 (Publication Type: Letter)
Topics
  • Behcet Syndrome (complications, diagnosis, drug therapy)
  • Humans
  • Uveitis (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: